Search Results - balveen+kaur

2 Results

Sort By:

Novel Oncolytic Herpes Simplex Virus (oHSV) for Cancer Treatment

Researchers from UTHealth have developed a novel oncolytic viral therapy, oHSV-shPKR, which can inhibit tumor cells’ antiviral PKR activity, and increase oncolytic virus infection and replication in both oncolytic viral-resistant and sensitive cancer cells. This novel oHSV-shPKR therapy can significantly increase the anti-tumor immune response...

Published: 8/15/2023 | Inventor(s): Balveen Kaur, BangXing Hong

Keywords(s):

Category(s): Biologics, Oncology, Therapeutics

Co-Administration of Oncolytic Herpes Simplex Virus (oHSV) with Cisplatin for Anti-Cancer Immunotherapy

Researchers from UTHealth and Ohio State University College of Medicine have collaborated to investigate the impact of oHSV therapy in combination with platinum agents using platinum-resistant high-grade serous ovarian carcinoma (HGSOC) as well as platinum-resistant ovarian clear cell carcinoma models. More importantly, they have developed a novel...

Published: 8/15/2023 | Inventor(s): Balveen Kaur

Keywords(s):

Category(s): Therapeutics, Oncology